Chediak-Higashi Syndrome

Subscribe to Selected New Research on Chediak-Higashi Syndrome

152 relevant articles (5 outcomes, 13 trials/studies) found for this Disease

Description: A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle.

Also Known As:

Chediak Higashi Syndrome; Syndrome, Chediak-Higashi

Relationship Network

Disease Context: Research Results

Hemic and Lymphatic Diseases

Hematologic Diseases: 1421

Leukocyte Disorders: 5

Phagocyte Bactericidal Dysfunction

Chediak-Higashi Syndrome: 152

Immune System Diseases: 1236

Immunologic Deficiency Syndromes: 68

Phagocyte Bactericidal Dysfunction

Chediak-Higashi Syndrome: 152

Aleutian Mink Disease: 15

Related Diseases

1.	Chronic Granulomatous Disease
2.	Syndrome
3.	Severe Combined Immunodeficiency (SCID)
4.	Infection
5.	Wiskott-Aldrich Syndrome (Syndrome, Wiskott-Aldrich)

Experts

1.	Ito, Katsuaki: 2 articles (12/2007 - 02/2002)
2.	Ikeda, Masahiro: 2 articles (12/2007 - 02/2002)
3.	Ohnishi, Katsuyuki: 1 article (12/2007)
4.	Honda, Naofumi: 1 article (12/2007)
5.	Fujishiro, Tsuyoshi: 1 article (12/2007)
6.	Ayas, M: 1 article (09/2007)
7.	Al-Ghonaium, A: 1 article (09/2007)
8.	Morimoto, Michiko: 1 article (07/2007)
9.	Kasai, Hirotake: 1 article (07/2007)
10.	Ito, Masahiko: 1 article (07/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Chediak-Higashi Syndrome:

1.	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/01/1979 - "Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice." 05/01/1982 - "After incubation with ascorbic acid, the clustered granules in the fibroblasts of the Chediak-Higashi syndrome showed a tendency to spread throughout the cytoplasm" 10/01/1979 - "Impaired microtubule assembly and polymorphonuclear leucocyte function in the Chediak-Higashi syndrome correctable by ascorbic acid." 05/01/1981 - "Development of the accelerated phase during ascorbic acid therapy in Chediak-Higashi syndrome and efficacy of colchicine on its management." 08/01/1992 - "A 10-year-old boy with Chediak-Higashi syndrome in accelerated phase failed to respond to treatment with ascorbic acid, vincristine, and prednisone" Order ALL the reference details at left...
2.	Peroxidase (Myeloperoxidase)IBA 08/01/1987 - "The present study has used ultrastructural cytochemistry to selectively stain myeloperoxidase containing granules of normal and Chediak-Higashi syndrome neutrophils and serial thin sections to determine if all peroxidase-positive organelles in Chediak-Higashi syndrome cells are protrusions of the huge inclusions characteristic of the disorder" 08/01/1987 - "Peroxidase-positive organelles in polymorphonuclear leukocytes from three patients with Chediak-Higashi syndrome varied in size from vesicles and normal-sized lysosomes to the huge bodies filling the cytoplasm" 12/01/1974 - "Fate of exogenous peroxidase in renal lysosomes of mice with Chediak-Higashi syndrome." 12/01/1987 - "These include examination of blood films, which may prove helpful in the diagnosis of Chediak-Higashi syndrome and specific granule deficiency; the Rebuck skin window test, which estimates chemotactic defects; the NBT test, which screens for chronic granulomatous disease patients; and peroxidase staining of the blood film in order to estimate the content of myeloperoxidase, when myeloperoxidase deficiency is suspected" 07/01/2000 - "Chediak-Higashi syndrome (CHS) is a rare autosomal-recessive disorder characterized by immune deficiency, partial oculocutaneous albinism, and large eosinophilic, peroxidase-positive inclusion bodies in granule-containing cells" Order ALL the reference details at left...
3.	Cholinergic Agents (Cholinergics)IBA 01/01/1977 - "The improvement in Chediak-Higashi syndrome polymorphonuclear leukocyte function by the addition of cholinergic agents and dibutyryl cGMP suggested disturbed intracellular cyclic nucleotide levels." 01/01/1977 - "The addition of cholinergic agents and cyclic 3'5'-guanosine monophosphate (cGMP) to polymorphonuclear leukocytes in vitro from a patient with Chediak-Higashi syndrome corrected the impaired release of the lysosomal enzyme, beta-glucuronidase, to normal" Order ALL the reference details at left...
4.	Colchicine FDA Link 05/01/1981 - "Development of the accelerated phase during ascorbic acid therapy in Chediak-Higashi syndrome and efficacy of colchicine on its management." Order ALL the reference details at left...
5.	Serotonin (5 Hydroxytryptamine)IBA 06/16/1986 - "The animal model of Chediak-Higashi syndrome used in the present study provides a unique opportunity to compare the kinetics of serotonin (5-hydroxytryptamine, 5-HT) uptake in platelets and brain synaptosomes in conditions of selective reduction of 5HT concentration in the platelets" 12/01/1976 - "The Chediak-Higashi syndrome is characterized by a serotonin platelet defect and neuronal dysfunction" 12/01/1976 - "Brain serotonin concentration and crude synaptosomal uptake in mice with the Chediak-Higashi syndrome." 10/01/1976 - "Platelets from two probands homozygous for the Chediak-Higashi syndrome have approximately 10% of the normal number of serotonin-containing dense bodies as visualized electron microscopically in air-dried whole mounts" 08/01/1976 - "Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets." Order ALL the reference details at left...
6.	Proteins (Proteins, Gene)IBA 04/01/1997 - "In addition, preliminary studies using antisense expression indicate that down-regulation of either Rab7 or Rab9 proteins induces severe cell vacuolation that resembles the phenotype seen in fibroblasts from patients with Chediak-Higashi syndrome." 11/30/2004 - "The beige and Chediak-Higashi syndrome (BEACH) domain defines a large family of eukaryotic proteins that have diverse cellular functions in vesicle trafficking, membrane dynamics, and receptor signaling" 01/01/2003 - "LvsB is most similar in sequence to the mammalian beige/Chediak-Higashi syndrome proteins and shares with them a common function in lysosomal trafficking" 01/01/2003 - "The identifying feature of these proteins is the BEACH domain named after the founding members of this family, the mouse beige and the human Chediak-Higashi syndrome proteins" 01/01/2002 - "The function of these proteins, which include the Chediak-Higashi syndrome (CHS) protein, Neurobeachin, LvsA, and FAN, is still poorly understood" Order ALL the reference details at left...
7.	Sepharose (Agarose)IBA 06/01/1982 - "This study investigated the defective natural killer (NK) cell activity in two patients with the Chediak-Higashi syndrome (CHS) using both a standard 51-chromium release microcytoxicity and a single cell-in-agarose assay against K562 and Molt-4 target cells" 06/01/1979 - "Chemotaxis of granulocytes in Chediak-Higashi syndrome with agarose plate and filter chamber methods." Order ALL the reference details at left...
8.	Membrane Proteins (Integral Membrane Proteins)IBA 12/01/1992 - "Further study will be necessary to delineate whether the function of these membrane proteins is altered in Chediak-Higashi syndrome." 10/22/1990 - "Identification of dense granule specific membrane proteins in bovine platelets that are absent in the Chediak-Higashi syndrome." Order ALL the reference details at left...
9.	EnzymesIBA 09/01/1986 - "Chediak-Higashi-syndrome cultured skin fibroblasts were used to study the possible involvement of lysosomal enzymes and lysosomal dysfunction in this disorder" 02/15/2002 - "In lvsB mutant cells, the regulated secretion of lysosomal enzymes was enhanced, a phenotype reminiscent of the Chediak-Higashi syndrome" 09/01/1986 - "Characterization of lysosomes and lysosomal enzymes from Chediak-Higashi-syndrome cultured fibroblasts." Order ALL the reference details at left...
10.	AgarIBA 01/01/1986 - "Studies on proliferation and differentiation of granulocyte-monocyte progenitor cells in Chediak-Higashi syndrome (CHS) were done on a 1-month-old patient, using the soft-agar bone marrow culture technique" 01/01/1975 - "Growth characteristics of bone marrow cells from beige mutant, the mouse homologue of the Chediak-Higashi syndrome of man, propagated in semisolid agar cultures." 01/01/1975 - "Suspensions of bone marrow cells from the beige (bg/bg) mouse, a homologue of the Chediak-Higashi syndrome (C-HS) of man, and normal mouse bone marrow cells, when stimulated by colony-stimu.ating factor (CSF) from different sources, proliferate in semisolid agar cultures and produce colonies composed of granulocytic and/or mononuclear cells" Order ALL the reference details at left...

Therapies and Procedures

1.	Transplants (Transplant) 11/01/1982 - "When spleen cells (1.5 x 10(8)) from beige C57BL/6 (bgJ/bgJ, Chediak-Higashi syndrome) mice were injected into nonirradiated (C57BL/6 x CBA)F1 hybrid mice, the hematopoietic stem cells of the hybrid host were eradicated by graft-versus-host (GVH) reaction, and peripheral neutrophils of the host changed from normal type to beige type with giant sudanophilic granules in 20 days after the cell injection" 07/01/2005 - "We also reviewed the very long-term outcome of the other 11 patients with Chediak-Higashi syndrome who had received bone marrow transplants at our center since 1981" 10/01/2003 - "An HLA-identical sibling bone marrow transplant was done for a patient with Chediak-Higashi syndrome" 10/01/2003 - "Fludarabine and once-daily intravenous busulfan is well tolerated and is adequate for engraftment of sibling transplant in Chediak-Higashi syndrome." Order ALL the reference details at left...
2.	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/01/2005 - "Three patients with Chediak-Higashi syndrome underwent allogeneic bone marrow transplantation between the ages of 2 years 9 months and 7 years" 01/01/2003 - "Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome." 06/01/2000 - "Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome." 06/01/1995 - "Allogenic bone marrow transplantation (BMT) has been proposed as a curative treatment for Chediak-Higashi syndrome" 06/01/1995 - "Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases." Order ALL the reference details at left...
3.	Splenectomy 08/01/1992 - "We suggest that splenectomy be considered in treatment of the accelerated phase of Chediak-Higashi syndrome unresponsive to other forms of therapy." 08/01/1992 - "Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy." 01/01/1988 - "Postulating a link between these findings and the known immunological defect of beige-J mice (Chediak-Higashi syndrome), we examined the effect of splenectomy on beige-J mice and the adoptive transfer of their mononuclear spleen cells to normal littermate controls (2 x 10(7) cells via tail vein)" 07/01/1985 - "Role of splenectomy in Chediak-Higashi syndrome in its accelerated phase]" 01/01/1970 - "Case of Chediak-Higashi syndrome treated with splenectomy]" Order ALL the reference details at left...
4.	Transplantation (Transplant Recipients) 04/01/1976 - "Transplantation of normal bone marrow to mice with the Chediak-Higashi syndrome (CHS) resulted in normal granulopoiesis and a reversal of their increased susceptibility to challenge with intravenous Candida albicans" 07/01/1992 - "Unrelated donor marrow transplantation was undertaken in eight infants with severe combined immunodeficiency (SCID) and two children each with Wiskott-Aldrich syndrome (WAS) and Chediak-Higashi syndrome (CHS) who did not have histocompatible siblings" Order ALL the reference details at left...
5.	Chemoprevention 04/01/1972 - "Cloxacillin chemoprophylaxis in the Chediak-Higashi syndrome." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Chediak-Higashi Syndrome

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 5 Outcomes
Top 200 Key Drugs and Biologics
Top 6 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>